Doubling of Serum Creatinine in Clinical Trials, Cost-Effectiveness Studies, and Individual Patients: Adequate Use in Renal Transplantation
Philippe Gatault(Centre Hospitalier Universitaire de Tours), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Alice M. Clement(Centre Hospitalier Universitaire de Tours), Yvon Lebranchu(Académie Nationale de Médecine), Christelle Barbet(Centre Hospitalier Universitaire de Tours), Azmi Al-Najjar(Université de Tours), Matthias Büchler(Centre Hospitalier Universitaire de Tours), Jean-Frédéric Marlière(Université de Tours), Mélanie Roland(Centre Hospitalier Universitaire de Tours), I. Laouad, P Métais, Hubert Nivet(Centre Hospitalier Universitaire de Tours)
Cited by 5
Related Papers
Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination
|Nature Genetics|2003|643
The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome
|Nature Genetics|2007|495
Immunoprophylaxis with Basiliximab Compared with Antithymocyte Globulin in Renal Transplant Patients Receiving MMF-containing Triple Therapy
|American Journal of Transplantation|2002|256
Spectrum of Mutations in Gitelman Syndrome
|Journal of the American Society of Nephrology|2011|239
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
|Nephrology Dialysis Transplantation|2017|228